🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

MEDP MEDP

Company Profile ↓
$587.75
+35.92% 1Y
P/E38.47
52W High$620.59
52W Low$393.42
EPS (TTM)$15.28

Company Overview

MEDP (MEDP) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 98.3%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 84.7%.

Consistent Profit Growth

Net profit has compounded at 25.4% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 21.6% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 17.8%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $2.53B (+20.0% YoY); net profit $451.12M.
  • Trailing 12 Months Year-on-year growth — revenue +20.0%, earnings +11.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 21.6%, profit CAGR 25.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:21.56%
1 Year:19.97%

Compounded Profit Growth

5 Years:25.42%
1 Year:11.56%

Stock Price Performance

1 Year:+35.92%
6 Months:+3.38%
3 Months:+36.58%
1 Month:+7.59%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 86% of range
$393.42 $620.59
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)63.55 · Neutral
Price Performance
1M+7.59%
3M+36.58%
6M+3.38%
1Y+35.92%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 98.3%.
  • Healthy ROCE of 84.7%.
  • Compounding revenue at 21.6% over 5 years.
  • Profit CAGR of 25.4% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
38.47
Industry PE
-
Forward P/E est.
34.48
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
21.56%
Profit 5Y
25.42%
Revenue (YoY)
19.97%
Earnings (YoY)
11.56%

Profitability & Returns

ROCE
84.68%
ROE
98.27%
ROA
22.84%
Profit Margin
17.83%
Op Margin
21.14%
Gross Margin
-
EPS (Latest Qtr)
$4.25
EPS (TTM)
$15.28

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$2.06B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
19.83%
Chg in Prom Hold
-
FII / Inst Holding
88.97%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$2.53B
EBITDA
-
Free Cash Flow
$681.87M
Operating Cash Flow
$713.22M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue --------106.61M106.22M110.64M112.68M163.08M170.14M179.25M192.12M200.74M214.10M216.24M229.89M230.88M205.00M230.37M259.96M278.29M295.57M330.95M351.21M383.74M434.07M460.87M492.50M511.04M528.10M533.32M558.57M603.31M659.90M706.60M707.33M
Operating Income 6.39M7.87M7.20M-889.00K12.87M14.11M12.62M12.89M15.94M16.28M17.20M15.44M20.12M23.34M26.92M30.67M25.89M35.26M29.99M36.12M35.50M30.13M46.42M47.60M42.45M53.71M64.20M60.24M77.83M86.20M78.39M84.91M104.07M105.15M112.27M113.52M126.33M141.81M141.50M146.82M
Net Income -59.00K95.00K-133.00K-8.58M3.45M4.96M5.04M-21.00K8.45M9.55M9.83M11.29M14.55M16.57M19.30M22.76M19.20M27.45M23.98M29.81M28.95M24.10M41.46M43.31M39.93M48.57M61.31M49.36M66.03M72.89M61.07M70.55M102.59M88.35M96.43M114.59M90.26M111.14M123.87M121.36M
Diluted EPS 0.000.000.00-0.270.110.150.130.000.200.230.250.300.400.450.520.610.510.730.630.780.760.641.091.141.061.291.691.462.052.271.932.223.202.753.013.673.103.864.284.25

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 359.06M421.58M436.15M704.59M860.97M925.92M1.14B1.46B1.89B2.11B2.53B
Operating Income 20.56M52.49M64.86M101.05M127.26M167.04M198.62M278.70M336.82M446.87M534.93M
Net Income -8.67M13.43M39.12M73.19M100.44M145.38M181.85M245.37M282.81M404.39M451.12M
Diluted EPS -0.280.370.981.972.673.844.817.288.8812.6315.28

Balance Sheet (Annual)

Figures in USD.

Metric Mar 2014Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Jan 2019Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --984.04M979.11M950.72M967.93M1.00B1.14B1.39B1.66B1.35B1.66B2.10B1.98B
Total Equity 414.00M401.97M413.47M610.71M509.26M598.86M598.86M726.28M805.78M952.93M386.39M558.95M825.54M459.07M
Cash & Equivalents --14.88M37.10M26.48M23.27M-131.92M277.77M461.30M28.27M245.45M669.44M497.05M
Long Term Debt --377.88M151.27M205.11M79.72M-0------
Total Liabilities --570.57M368.39M447.19M378.23M405.92M416.79M584.90M707.01M966.11M1.10B1.28B1.52B
Current Liabilities --134.02M168.60M192.71M257.03M263.12M343.00M440.11M557.22M803.47M925.13M1.10B1.34B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -91.73M97.39M156.58M201.87M258.68M263.33M388.05M433.37M608.82M713.22M
Investing Cash Flow --13.42M-12.24M-16.97M-19.14M-31.21M-31.36M-38.74M-34.63M-28.31M-31.14M
Financing Cash Flow --58.01M-97.83M-141.58M-73.92M-82.28M-44.45M-775.77M-182.64M-154.01M-860.39M
Capital Expenditure -6.46M-13.54M-11.72M-16.02M-17.91M-31.34M-28.27M-36.88M-36.65M-36.55M-31.36M
Free Cash Flow -78.19M85.66M140.56M183.96M227.34M235.06M351.17M396.73M572.27M681.87M
Share Buybacks 00155.58M0098.27M62.10M847.85M144.02M169.87M917.39M

Ratios (Annual)

Figures in %.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------
Operating Margin % 5.7%12.5%14.9%14.3%14.8%18.0%17.4%19.1%17.9%21.2%21.1%
Net Margin % -2.4%3.2%9.0%10.4%11.7%15.7%15.9%16.8%15.0%19.2%17.8%
ROE % -2.1%2.2%7.7%12.2%13.8%18.0%19.1%63.5%50.6%49.0%98.3%
ROCE % 2.4%6.5%8.6%14.2%15.9%17.6%18.0%50.8%46.0%44.9%84.7%

Shareholding Pattern

Insiders
19.83%
Institutions
88.97%
Public Float
110.97%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MEDP

Google News Fri, 31 Jul 2026

Medpace Holdings Inc (MEDP) Stock Price & News - Google Finance - Google

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1ZaWw2V01uYnRGbGtEX1B6Z0JFcUhiczVNeHBCX2xnSDhGWVNpT2lLa2xOSGxMeWNTSF91OTl6SU5vMzkyUVMtLXBvczJBOTJENGlDY1lfUmZxbURF?oc=5" target="_blank">Medpace Holdings Inc (MEDP) Stock Price & N…

Google News hu, 23 Jul 2026

Why Is Medpace (MEDP) Stock Soaring Today - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPcTVIZUdLZTBaandObXFra1FNRUJMcTlOT2ZvRm0zVktwLUxWMWRBTVNwZEd3UUVOZ0NvVkJiUEtsZ2NObzZmeFYwd0xSc0xYSXJhdXdHMEVlcjVnNVc1cXlCT0RtYW9neHNGQWJtWmt4UGNSbGhOOE9oUVR1aGM1TzZyUXcwakIwR1pMV1…

Google News hu, 23 Jul 2026

Medpace Notches A Surprise Beat, Sending Shares Skyward - Investor's Business Daily

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZks5X3ZNdFJxZllXb2R3eXlXbkhtYXBTMWlpcnoweXFyVThRd0VIYnZBY2ROWnNhSnh2UUlkdTNpVjBYR3NpLXYtcDBzVlhjWDlEZDBrSGgyeHg0VE40MldzV2dCR2taV1ZDeVpyUm9EdHJCN3hnMjA2ODZhUlgwa1lzYzRZNXNV?oc=5"…

Google News Sun, 26 Jul 2026

Medpace (MEDP) Stock May Be Below Fair Value On Raised Guidance - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPNGdLc195cVRJNTVKa0F0NVpicXJpVVZrRjJMWnYtaFpNTTcxZmpIWG1wMkdZY3JIYUxpS0JFUHdXZ1h0MDhhRzFKTEtpSFBlTzF5RC05aXkxNEZCVk1vem1OQ0o3RFl6NWR5OEtLa2JveHNtZVgtRHpwMnV2NzEwNFRfaUdRZ0pnR1QwR0…

Google News Wed, 22 Jul 2026

MEDPACE HOLDINGS ($MEDP) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPZFdCRll3Q1lPbExqZUg1YXY1OFpGcXVFaEJBV2FXcm9GTGRWRG1URnlHVVoxU3V4TFZpbWZ6em5HU3E1Umtjc0V2TGNjRHJ2SEg2SlRsby1nMDBCZW53eHBYQXZsaWJ3NHNKS21XQ1AyTFVZbWJOZGZjaU9UNXhKUndEUjZodEFiaDhidn…

Google News Wed, 22 Jul 2026

Medpace Holdings (NASDAQ:MEDP) Jumps 17% After Q2 Earnings Beat and Raised Guidance - ChartMill

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPR0NNVGRkcGk3QU95NF9GTW9ReVFWYk9iN1Y2cnJ0Rk1KVHUzYjBiNno2Sy1wT00wU2MteXNOdzRvRVhGNWhKMVp6dENTbVRBZHJHYXhQT3NFVkN4WHdONExPTE9nOXlYeEJ2bU15WktYZnk2UlBxM1B3R3BlRkRrWDN2Tm9jbUlnZTFzeU…

MEDP — Frequently Asked Questions

What is the current share price of MEDP?

As of 2026-08-05 17:25 PDT, MEDP trades at $587.75 on NASDAQ/NYSE. Its 52-week range is $393.42 to $620.59.

What is the P/E ratio of MEDP?

MEDP trades at a trailing price-to-earnings (P/E) ratio of 38.47.

What is the return on equity (ROE) of MEDP?

MEDP has a return on equity (ROE) of 98.27%. Its return on capital employed (ROCE) is 84.68%.

Is MEDP a good stock to buy?

This page provides a data-driven analysis of MEDP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space